Want to test your knowledge about stem cells with this not-so-trivial trivia? Let’s see if you can do better than Giuliano and Nicola! (You probably can, especially better than Nicola…).

Thanks to Ulla-Kaisa Peteri for preparing the questions!

They can, and while this is mostly okay, it’s also one of the reasons we age—and we just might be able to do something about it.

Last July, the Life Extension Advocacy Foundation hosted a great conference on rejuvenation biotechnology in New York City; if you missed it, this episode of X10 will fill you in on some of the best talks of the conference.

Full playlist of all talks: https://bit.ly/2pP2BE6

How well will they do, and is life extension accurately portrayed in popular fiction? Let’s find out!

Here’s how genomic instability messes with your body and contributes to aging.

Click on photo to start video.

Well, considering he’d never heard of him…

Should we stop this whole life extension thing while we still can in order to prevent this potential problem? Yeah… no. Here’s why.

Click on photo to start video.

Let’s take a look at the history of life extension and some of humanity’s attempts €”some promising, some hilariously wrong €”to cheat aging and death.

Prof. S. Jay Olshansky is a Professor of the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine, and Chief Scientist at Lapetus Solutions, Inc. He has received multiple scientific awards, including the Irving S. Wright Award from the American Federation for Aging Research.

Prof. Olshansky is the co-author of multiple papers related to epidemiology and population, and the areas of his current research include estimates of the upper limits to human longevity, opportunities and challenges related to population aging, how morbidity changes over time, and forecasts of the size and age demographics of the population with and without medicines that address the underlying mechanisms of aging.

We had the opportunity to interview Prof. Olshansky at International Perspectives in Geroscience, a conference hosted at Weizmann Institute of Science (Israel) on September 4–5.

We’re continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology.

Today, we’re releasing a talk from Dr. Doug Ethell, who announced his company’s efforts to combat Alzheimer’s disease, describing where and how this neurodegenerative disease starts and discussing his company’s work on developing therapies for the cribiform plate, which naturally clears amyloid-forming proteins from the brain before they aggregate.